FI20106293A0 - Uudet farmaseuttiset koostumukset - Google Patents

Uudet farmaseuttiset koostumukset

Info

Publication number
FI20106293A0
FI20106293A0 FI20106293A FI20106293A FI20106293A0 FI 20106293 A0 FI20106293 A0 FI 20106293A0 FI 20106293 A FI20106293 A FI 20106293A FI 20106293 A FI20106293 A FI 20106293A FI 20106293 A0 FI20106293 A0 FI 20106293A0
Authority
FI
Finland
Prior art keywords
nortrachelogenin
lignan
dibenzylbutyrolactone
hydroxy
treating cancer
Prior art date
Application number
FI20106293A
Other languages
English (en)
Swedish (sv)
Inventor
Emilia Peuhu
John Eriksson
Thomas Holmbom
Patrik Eklund
Rainer Sjoeholm
Original Assignee
Emilia Peuhu
John Eriksson
Thomas Holmbom
Patrik Eklund
Rainer Sjoeholm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emilia Peuhu, John Eriksson, Thomas Holmbom, Patrik Eklund, Rainer Sjoeholm filed Critical Emilia Peuhu
Priority to FI20106293A priority Critical patent/FI20106293A0/fi
Publication of FI20106293A0 publication Critical patent/FI20106293A0/fi
Priority to PCT/FI2011/051080 priority patent/WO2012076756A2/en
Priority to US13/991,906 priority patent/US9168243B2/en
Priority to CA2820416A priority patent/CA2820416A1/en
Priority to RU2013127152/15A priority patent/RU2013127152A/ru
Priority to EP11805551.6A priority patent/EP2648720A2/en
Priority to US14/922,228 priority patent/US20160120937A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1761—Apoptosis related proteins, e.g. Apoptotic protease-activating factor-1 (APAF-1), Bax, Bax-inhibitory protein(s)(BI; bax-I), Myeloid cell leukemia associated protein (MCL-1), Inhibitor of apoptosis [IAP] or Bcl-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI20106293A 2010-12-06 2010-12-06 Uudet farmaseuttiset koostumukset FI20106293A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20106293A FI20106293A0 (fi) 2010-12-06 2010-12-06 Uudet farmaseuttiset koostumukset
PCT/FI2011/051080 WO2012076756A2 (en) 2010-12-06 2011-12-07 New pharmaceutical compositions
US13/991,906 US9168243B2 (en) 2010-12-06 2011-12-07 Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans
CA2820416A CA2820416A1 (en) 2010-12-06 2011-12-07 New pharmaceutical compositions
RU2013127152/15A RU2013127152A (ru) 2010-12-06 2011-12-07 Фармацевтические композиции, содержащие 8-замещенные дибензилбутиролактоновые лигнаны
EP11805551.6A EP2648720A2 (en) 2010-12-06 2011-12-07 New pharmaceutical compositions
US14/922,228 US20160120937A1 (en) 2010-12-06 2015-10-26 Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20106293A FI20106293A0 (fi) 2010-12-06 2010-12-06 Uudet farmaseuttiset koostumukset

Publications (1)

Publication Number Publication Date
FI20106293A0 true FI20106293A0 (fi) 2010-12-06

Family

ID=43414987

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20106293A FI20106293A0 (fi) 2010-12-06 2010-12-06 Uudet farmaseuttiset koostumukset

Country Status (6)

Country Link
US (2) US9168243B2 (fi)
EP (1) EP2648720A2 (fi)
CA (1) CA2820416A1 (fi)
FI (1) FI20106293A0 (fi)
RU (1) RU2013127152A (fi)
WO (1) WO2012076756A2 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20106293A0 (fi) * 2010-12-06 2010-12-06 Emilia Peuhu Uudet farmaseuttiset koostumukset
CA3149681A1 (en) * 2019-08-02 2021-02-11 Oy Granula Ab Ltd A method and a compound for preventing mammalian cancer cell proliferation and for treating cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284236B1 (en) * 1995-06-29 2001-09-04 Immunex Corporation Cytokine that induces apoptosis
US6451849B1 (en) * 1999-03-30 2002-09-17 Hormos Nutraceutical Oy Ltd. Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol
WO2002034277A1 (en) * 2000-10-23 2002-05-02 Council Of Scientific And Industrial Research Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara
US20020115613A1 (en) * 2001-02-16 2002-08-22 Kumar M. Vijay Treatment of prostate cancer
CN100475848C (zh) 2001-05-18 2009-04-08 麒麟麦酒株式会社 抗trail-r抗体
WO2003047608A1 (en) 2001-12-05 2003-06-12 Council Of Scientific And Industrial Research A novel herbal chemical composition for the treatment of cancer
US20030144216A1 (en) 2002-01-25 2003-07-31 Mikko Unkila Method for prevention of diseases in coeliac patients
FI20021184A (fi) 2002-06-19 2003-12-20 Hormos Nutraceutical Oy Ltd Lignaanivalmisteita
US20070117864A1 (en) * 2003-12-26 2007-05-24 Tokyo University Of Agr. & Tech. Tlo Co., Ltd. Composition for preventing and treating hepatoma
CN100577677C (zh) 2005-08-26 2010-01-06 中国人民解放军军事医学科学院毒物药物研究所 络石藤总木脂素提取物,提取方法及该提取物和其中有效成分的医药用途
FI20106293A0 (fi) * 2010-12-06 2010-12-06 Emilia Peuhu Uudet farmaseuttiset koostumukset

Also Published As

Publication number Publication date
US20160120937A1 (en) 2016-05-05
WO2012076756A3 (en) 2012-08-16
WO2012076756A2 (en) 2012-06-14
EP2648720A2 (en) 2013-10-16
US20130281381A1 (en) 2013-10-24
CA2820416A1 (en) 2012-06-14
US9168243B2 (en) 2015-10-27
RU2013127152A (ru) 2015-01-20

Similar Documents

Publication Publication Date Title
DOP2014000115A (es) Uso de 4-fenil-piridinas sustituidas para la fabricación de medicamentos útiles en el tratamiento de enfermedades relacionadas con el receptor de nk1
ECSP14013325A (es) Piridopirazinas anticancerigenas via la inhibicion de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr)
EA201101190A1 (ru) Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение
MX2012012277A (es) Compuestos organicos.
CL2013000016A1 (es) Compuestos derivados de imidazopiridina; procedimiento de preparacion; composicion farmaceutica y su uso en el tratamiento del cancer.
MX2014012374A (es) Compuestos organicos.
CL2007001711A1 (es) Compuestos derivados de pirazolopiridina sustituida;composicion farmaceutica que los comprende;metodo de preparacion de los compuestos ,compuestos intermediarios;y su uso en el tratamiento de enfermedades,tales como tumores,artritis reumatoide,enfermedades del crecimiento vascular desregulado, entre otras.
UA114907C2 (uk) Гетероциклільні сполуки як інгібітори mek
EA201200618A1 (ru) Производные хроменона с антиопухолевой активностью
UY31619A1 (es) Compuestos espiro como antagonistas del receptor npy y5
WO2012142511A3 (en) Orthomolecular compositions and their use in stabilizing the extracellular matrix
CL2007001710A1 (es) Compuestos derivados de amino-pirazolopiridina sustituidos; metodo de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como tumores, artritis reumatoide, enfermedades de crecimiento vascular desregulado, entre otras.
EA201401351A1 (ru) Производные бензимидазол-пролина
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
MY156332A (en) Quinuclidine carbonate derivatives and medicinal composition thereof
MY175800A (en) Combination treatment of cancer
MX2012007806A (es) Composiciones farmaceuticas para administracion oral de peptidos de insulina.
UA107334C2 (ru) Производные аминоэфиров алкалоидов и их лекарственные композиции
CL2015002202A1 (es) Benzamidas sustituidas con actividad hacia receptores ep4.
EA201590873A1 (ru) Соединения, обладающие активностью антагонистов мускариновых рецепторов и агонистов бета2 адренергических рецепторов
EA201190142A1 (ru) Производные пиразола, используемые в качестве антагонистов рецептора ccr4
EA201400623A1 (ru) Новые 2h-индазолы в качестве антагонистов рецептора ep
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
MX2014000964A (es) Derivados aza heterociclicos sustituidos.
EA201290808A1 (ru) Замещенные конденсированные производные имидазола, фармацевтические композиции и способы их применения

Legal Events

Date Code Title Description
FD Application lapsed